WELLCOME PROFESSORSHIP IN CLINICAL PHARMACOLOGY
Established in 1971 by the Burroughs Wellcome Fund

The BURROUGHS WELLCOME FUND is an independent private foundation dedicated to advancing the medical sciences by supporting research and other scientific and educational activities. It conducts a majority of its grant-making through competitive programs designed to support the career development of young scientists and to build capacity in research areas the fund believes to be undervalued or in need of targeted support. The fund's board of directors is composed of distinguished scientists and business leaders, and the fund has, for several decades, been a leader in supporting medical research and training programs. Every year, the fund awards milions of dollars to universities, research centers, and foundations.

 

THERESA A. SHAPIRO, Med 1976, 1978 (PhD), the Wellcome Professor of Clinical Pharmacology, is director of the Division of Clinical Pharmacology, and professor of medicine and of pharmacology and molecular sciences. Her research is focused on the discovery and development of new drugs for sleeping sickness and malaria. Her investigator-initiated trial of atovaquone was pivotal for FDA approval of this agent for use in malaria chemprophylaxis. Dr. Shapiro has served on expert committees for the World Health Organization, the U.S. Food and Drug Administration, the National Institutes of Health, and the U.S. Pharmacopeia.